Browse by category

First participant dosed in Terns’ trial of TERN-601 oral GLP-1ra for treatment of obesity

Terns Pharmaceuticals has announced that the first participant has been dosed in the Phase 1 clinical trial of TERN-601, the company’s...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

5 days ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

5 days ago

Racial and ethnic groups face barriers to obtaining OMMs

5 days ago

Weekly Digest